tamibarotene has been researched along with Autoimmune Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bradley, CP; Felix, KM; Naskar, D; Teng, F; Wu, HJ | 1 |
Keino, H; Okada, AA; Sato, Y; Watanabe, T | 1 |
Fukasawa, H; Kagechika, H; Shudo, K | 1 |
1 review(s) available for tamibarotene and Autoimmune Disease
Article | Year |
---|---|
[Retinoid therapy for autoimmune diseases].
Topics: Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Benzoates; Humans; Leukemia, Promyelocytic, Acute; Receptors, Retinoic Acid; Retinoids; Skin Diseases; T-Lymphocytes; Tetrahydronaphthalenes; Tretinoin | 2006 |
2 other study(ies) available for tamibarotene and Autoimmune Disease
Article | Year |
---|---|
Synthetic Retinoid AM80 Ameliorates Lung and Arthritic Autoimmune Responses by Inhibiting T Follicular Helper and Th17 Cell Responses.
Topics: Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Autoimmunity; Benzoates; Cell Differentiation; Disease Models, Animal; Integrins; Intestines; Lung; Lymph Nodes; Mice; Peyer's Patches; T-Lymphocytes, Helper-Inducer; Tetrahydronaphthalenes; Th17 Cells | 2017 |
Oral administration of retinoic acid receptor-alpha/beta-specific ligand Am80 suppresses experimental autoimmune uveoretinitis.
Topics: Administration, Oral; Animals; Autoimmune Diseases; Benzoates; CD4-Positive T-Lymphocytes; Disease Models, Animal; Eye Proteins; Female; Flow Cytometry; Forkhead Transcription Factors; Gene Expression; Interleukin-17; Ligands; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Receptors, Interleukin-6; Receptors, Retinoic Acid; Retinitis; Retinoic Acid Receptor alpha; Retinol-Binding Proteins; Tetrahydronaphthalenes; Uveitis | 2011 |